Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Income Statement [Abstract]    
Revenue $ 0 $ 0
Operating expenses:    
Research and development costs 690,937 916,249
Compensation expense 1,544,751 1,429,150
Director fees 256,490 273,230
Legal and professional 809,489 586,207
General and administrative 1,090,347 418,145
Total operating expenses 4,392,014 3,622,981
Loss from operations (4,392,014) (3,622,981)
Other income (expense):    
Gain on forgiveness of Paycheck Protection Program loan 0 75,979
Interest income 157,645 0
Interest expense (509) (3,046)
Other expense, net (4,283) (1,188)
Total other income, net 152,853 71,745
Net loss $ (4,239,161) $ (3,551,236)
Basic loss per share $ (0.27) $ (2.45)
Diluted loss per share $ (0.27) $ (2.45)
Weighted average shares outstanding basic 15,521,654 1,448,285
Weighted average shares outstanding diluted 15,521,654 1,448,285